REACTIVE (TOXIC) HEPATITIS AS COMPLICATION OF THE MEASLES IN MILITARY SERVICEMEN
DOI:
https://doi.org/10.11603/1681-2727.2019.4.10957Keywords:
measles, reactive (toxic) hepatitis, clinical and laboratory manifestationsAbstract
The aim of the work – to study the incidence of hepatitis, its clinical and laboratory manifestations in measles in military personnel during the last measles epidemic in Ukraine in order to improve the effects of treatment.
Materials and methods. In order to study the frequency of development of hepatitis, clinical and laboratory manifestations of measles in military personnel during the last epidemic in Ukraine, 235 medical records of inpatients with measles, who were hospitalized at the Hospital of Infectious Diseases of the National Military Medical Clinical Center «The Main Military Clinical Hospital», were analyzed for the period from 01.01.2018 till 12.31.2018.
Research results. Complications in the form of reactive (toxic) hepatitis were detected in 29 % of measles patients. The highest percentage of patients with a complication of hepatitis by months was in May – 40 % of patients, in June – 46.6 %, in November – 83.3 %, in December – 28.1 %. Mainly hepatitis was registered in conscripts (49 % of patients) and officers – in 22 % of patients. Reactive (toxic) hepatitis was more often diagnosed on Me=7 days from the moment of illness (Q25=6, Q75=8), and from the day of hospitalization on Me=2 days, (Q25=2, Q75=4).
In 72.5 % of patients, hepatitis was diagnosed on the background of high body temperature, in 27.5% – on the background of normal body temperature. In patients with hepatitis, the maximum body temperature was predominantly febrile (47.8 %) and pyrethic in 39.1 %. Complaints and symptoms of gastrointestinal lesions showed 30.4 % of patients (nausea – 14.5 %, feeling of discomfort in the abdomen – 11.6 %, loose stool – 10.1 %, vomiting – 8.7 %. The number of leukocytes in 68 % was within the normal range, the leukopenia – in 23 %, the leukocytosis – in 9 %. In patients with measles, complicated by reactive hepatitis, at admission to treatment was leukopenia, in the future the level of leukocytes increased and reached the maximum values for 13-15 days from the disease, but the level of norm did not exceed. Preferably, the granulocyte indices were within the normal range. The maximum mean AlAT and AsAT levels were 4–6 days of disease Me=(115.8±85.1), min=17.7, max=391 and Me=(87.3±85.1), min=64.9, max=119.9, and from 10–12 days began to return to normal. With complications for hepatitis + pancreatitis, the mean AlAT values throughout the disease period were above normal, and the maximum values reached 10–12 days of the disease. Palpator size of the liver and spleen did not increase.
Conclusions. In young people, measles can be complicated by reactive (toxic) hepatitis. In the vast majority of patients, complications were diagnosed only after biochemical blood tests, due to the low incidence of complaints (nausea in 14.5 %, discomfort in the hypochondrium – in 11.6 %, vomiting – in 8.7 %, decreased appetite – 2.9 %), so the real incidence of hepatitis is much higher than detected (29 %).
More often reactive (toxic) hepatitis was diagnosed on Me=7 days from the moment of the disease (Q25=6, Q75=8) both on the background of the raised and normal body temperature, both on the background of other complications and without them.
Taking into account either insignificant or completely absent symptoms in the liver, pancreas against the background of the cortex of the mild and moderate course, in order to eliminate complications of these organs in the cortex, it is necessary to carry out mandatory examinations for AlАT, AsAT, blood amylase, diastasis period from 3 to 9 days from the beginning of the disease, even when patients have no complaints.
References
Monthly measles and rubella monitoring report February 2020 Period covered: 1 January 2019–31 December 2019. Electronic resource. Retrieved from: https://www.ecdc.europa.eu/sites/default/files/images/EMMO_Rates_Last12Months_MEAS_14.png
Monthly measles and rubella monitoring report January 2020 Period covered: 1 December 2018-30 November 2019. Electronic resource. Retrieved from: https://www.ecdc.europa.eu/sites/default/files/documents/measels-rubella-monthly-report-january-2020.pdf
Communicable disease threats report. Electronic resource. Retrieved from: https://www.ecdc.europa.eu/sites/default/files/documents/communicable-disease-threats-report-11-jan-2020-PUBLIC.pdf
Leibovici, L., Sharir T., Kalter-Leibovici, O., Alpert, G., Epstein, L. M. (1988). An outbreak of measles among young adults. Clinical and laboratory features in 461 patients. J. Adolesc. Health Care, 9 (3), 203-207. DOI: https://doi.org/10.1016/0197-0070(88)90072-1
Gavish, D., Kleinman, Y., Mora, A., & Chajek-Shaul, T. (1983). Hepatitis and jaundice associated with measles in young adults. An analysis of 65 cases. Arch. Intern. Med., 143 (4), 674-677. DOI: https://doi.org/10.1001/archinte.1983.00350040064008
Casanova-Cardiel, L. J., & Hermida-Escobedo, C. (1994). Measles in the young adult. Clinical features of 201 cases. Rev. Invest. Clin., 46 (2), 93-98.
Mouallem, M., Friedman, E., Pauzner, R., & Farfel, Z. (1987). Measles epidemic in young adults. Clinical manifestations and laboratory analysis in 40 patients. Arch. Intern. Med., 147 (6), 1111-1113. DOI: https://doi.org/10.1001/archinte.1987.00370060107018
Dinh, A., Fleuret, V., & Hanslik, T. (2013). Liver involvement in adults with measles. International Journal of Infectious Diseases, 17 (12), 1243-1244. DOI: https://doi.org/10.1016/j.ijid.2013.06.014
Grammens, T., Schirvel, C., Leenen, S., Shodu, N., Hutse, V., Mendes da Costa, E., & Sabbe, M. (2017). Ongoing measles outbreak in Wallonia, Belgium, December 2016 to March 2017: characteristics and challenges. Euro Surveill., 22 (17), 30524. DOI: https://doi.org/10.2807/1560-7917.ES.2017.22.17.30524
Downloads
Published
How to Cite
Issue
Section
License
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0